SCHEMBL10864909

SCHEMBL10864909

CCOC(=O)[C@@H](C)OC(=O)OC1=C(C)NC(C)=C(c2nnco2)C1c1cccc(Cl)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.44
KMT2A Q03164 5/20 0.44
CYP1A2 P05177 4/20 0.44
CYP3A4 P08684 4/20 0.44
CYP2C19 P33261 4/20 0.44
MEN1 O00255 3/20 0.44
ABCB11 O95342 3/20 0.44
LMNA P02545 3/20 0.44
TSHR P16473 3/20 0.44
KDM4E B2RXH2 2/20 0.44
HIF1A Q16665 2/20 0.44
HSD17B10 Q99714 2/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
CYP2D6 P10635 2/20 0.44
NR1I2 O75469 2/20 0.44
NR3C1 P04150 2/20 0.44
ADORA3 P0DMS8 2/20 0.44
TBXA2R P21731 2/20 0.44
OPRK1 P41145 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10868478 1.00 CYP2C9 (0.44) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL7263830 0.91 CYP2C9 (0.39) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL10866129 0.88 KMT2A (0.45) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL7272930 0.88 KMT2A (0.45) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL10625492 0.87 CYP2C9 (0.53) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL10870367 0.86 ALDH1A1 (0.43) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL7272913 0.85 KMT2A (0.46) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL10867143 0.84 KDM4E (0.42) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL10862617 0.84 KMT2A (0.42) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL10869697 0.81 TP53 (0.38) CYP2C9KMT2ACYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0172509-A2 Process for the preparation of optically active, substituted 1,4-dihydropyridines and their use as medicaments CASSELLA Aktiengesellschaft (DE) 1986-02-26 EP disclosed